Filing Details

Accession Number:
0001209191-23-006204
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-02-02 16:14:45
Reporting Period:
2023-01-31
Accepted Time:
2023-02-02 16:14:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1197036 I Bruce Sachs C/O Vertex Pharmaceuticals Incorporated
50 Northern Ave
Boston MA 02210
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-01-31 1,200 $72.14 42,410 No 4 M Direct
Common Stock Disposition 2023-01-31 1,200 $325.01 41,210 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2023-01-31 1,200 $0.00 1,200 $72.14
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
21,300 2024-05-31 No 4 M Direct
Footnotes
  1. Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1.
  2. Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
  3. Open market sales reported on this line occurred at a weighted average price of $325.01 (range $325.00 to $325.01).
  4. Fully vested.